+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

  • PDF Icon

    Report

  • 136 Pages
  • March 2024
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5977228
Description Jump to:
The Asia Pacific infectious disease diagnostics market was valued at US$4.67 billion in 2022 and is expected to reach US$8.16 billion by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Rising Number of Product Approvals and Launches Drives Asia Pacific Infectious Disease Diagnostics Market

The small and big companies operating in the Asia Pacific infectious disease diagnostics market adopt various strategies such as regional expansion, new product launches, and technological advancements to increase their revenue. Infectious disease diagnostic products are safer and more effective than before with continued developments and technological advancements.

Following are a few recent developments in infectious disease diagnostics market:

In August 2023, Danaher Corp entered into a definitive agreement to acquire Abcam plc. Danaher would acquire all of the outstanding shares of Abcam for US$ 24.00 per share in cash, or a total enterprise valued of approximately US$ 5.7 billion including assumed indebtedness and net of acquired cash.

In May 2021, Torus Biosystems launched the US$ 25 million program to advance infectious disease diagnostics across healthcare facilities.

In December 2021, Roche launched the first infectious illness tests on the Cobas 5800 System, a new molecular laboratory instrument. Cobas HIV-1/HIV-2 Qualitative, Cobas HBV, cobas HCV, cobas HIV-1, and Cobas Omni Utility Channel kit are a few of these options.

In June 2021, Bio-Rad Laboratories launched PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, an accurate, sensitive, and cost-effective tool used to detect SARS-CoV-2 in a community's wastewater.

In April 2020, CerTest Biotec and B.D. (Becton, Dickinson, and Company) announced that VIASURE SARS-CoV-2 Real-Time PCR Detection Kit adapted for the BD MAX System has been CE marked to the IVD Directive (98/79/C.E.).

The active participation of market participants in product innovation and development and an increase in product approvals are likely to boost the growth of the Asia Pacific infectious disease diagnostics market during 2022-2030.

Asia Pacific Infectious Disease Diagnostics Market Overview

According to a ChinaTown Online blog, in May 2022, ~1 in 7 people from the age range of 15-49 is infected with sexually transmitted diseases (STDs) in China. Chlamydia, gonorrhea, genital warts, and syphilis are the most common STDs. According to the WHO, overall ~370 million new cases of trichomoniasis, Neisseria gonorrhea (NG) infection, Chlamydia trachomatis (CT) infection, and syphilis, among others, were detected in China in 2020. ~35% of the new infections registered were CT, which is one of the world's most commonly reported sexually transmitted infections (STIs). Further, the rising number of public-public and public-private partnerships to address challenges posed by infectious disease burden in the country is expected to boost the market growth in the coming years. For Instance, the Centers for Disease Control and Prevention (CDC, US) has been in collaboration with the Government of China, along with other partners based in the country, for ~30 years, addressing public health priorities that affect the US, China, and the world.

Asia Pacific Infectious Disease Diagnostics Market Segmentation

The Asia Pacific infectious disease diagnostics market is segmented based on product, technology, application type, testing type, end user, and country.

Based on product, the Asia Pacific infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held the largest share in 2022.

By technology, the Asia Pacific infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the Asia Pacific infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held a larger share in 2022.

By testing type, the Asia Pacific infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held a larger share in 2022. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the Asia Pacific infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held the largest share in 2022.

Based on country, the Asia Pacific infectious disease diagnostics market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific infectious disease diagnostics market in 2022.

Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories Inc, and DiaSorin SpA are some of the leading companies operating in the Asia Pacific infectious disease diagnostics market.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Asia Pacific Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Infectious Disease Diagnostics Market - Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Rising Incidence of Infectious Diseases
4.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
4.2 Market Restraints
4.2.1 Inadequate Reimbursement Scenario
4.3 Market Opportunities
4.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
4.4 Future Trends
4.4.1 Rising Number of Product Approvals and Launches
4.5 Impact Analysis:
5. Infectious Disease Diagnostics Market - Asia Pacific Market Analysis
5.1 Asia Pacific Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
6. Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
6.3 Kits & Reagents
6.3.1 Overview
6.3.2 Kits & Reagents: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Instruments
6.4.1 Overview
6.4.2 Instruments: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Software & Services
6.5.1 Overview
6.5.2 Software & Services: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology
7.1 Overview
7.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
7.3 Biosensor-based
7.3.1 Overview
7.3.2 Biosensor-based: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Immunodiagnostics
7.4.1 Overview
7.4.2 Immunodiagnostics: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
7.5 Molecular-Based Diagnostic Techniques
7.5.1 Overview
7.5.2 Molecular-Based Diagnostic Techniques: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
7.6 Clinical Biology
7.6.1 Overview
7.6.2 Clinical Biology: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type
8.1 Overview
8.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
8.3 Point-of-Care Testing
8.3.1 Overview
8.3.2 Point-of-Care Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Laboratory Testing
8.4.1 Overview
8.4.2 Laboratory Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type
9.1 Overview
9.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
9.3 Human Testing
9.3.1 Overview
9.3.2 Human Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
9.4 Veterinary Testing
9.4.1 Overview
9.4.2 Veterinary Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.2 Diagnostic Laboratories: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals and Clinics
10.4.1 Overview
10.4.2 Hospitals and Clinics: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research Institutes
10.5.1 Overview
10.5.2 Research Institutes: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Homecare Settings
10.6.1 Overview
10.6.2 Homecare Settings: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
11. Asia Pacific Infectious Disease Diagnostics Market - Country Analysis
11.1 Asia Pacific Infectious Disease Diagnostics Market - Country Analysis
11.1.1 Asia Pacific Asia Pacific Infectious Disease Diagnostics Market, by Country
11.1.1.1 China
11.1.1.1.1 Overview
11.1.1.1.2 China: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.3 China: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.1.4 China: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.1 China: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.2 China: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.1.5 China: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.1.6 China: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.6.1 China: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.7 China: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Japan
11.1.1.2.1 Overview
11.1.1.2.2 Japan: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.3 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.2.4 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.1 Japan: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.2 Japan: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.2.5 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.2.6 Japan: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.6.1 Japan: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.7 Japan: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 India
11.1.1.3.1 Overview
11.1.1.3.2 India: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.3 India: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.3.4 India: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.1 India: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.2 India: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.3.5 India: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.3.6 India: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.6.1 India: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.7 India: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 South Korea
11.1.1.4.1 Overview
11.1.1.4.2 South Korea: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.3 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.4.4 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.4.4.1 South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.4.4.2 South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.4.5 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.4.6 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.4.6.1 South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.4.7 South Korea: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Australia
11.1.1.5.1 Overview
11.1.1.5.2 Australia: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.3 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.5.4 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.5.4.1 Australia: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.5.4.2 Australia: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.5.5 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.5.6 Australia: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.5.6.1 Australia: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.5.7 Australia: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 Rest of Asia Pacific
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.3 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.6.4 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.6.5 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.6.6 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.6.6.1 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.6.7 Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bruker Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cardinal Health Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Trinity Biotech Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AccuBioTech Co Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ACON Laboratories Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 DiaSorin SpA
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Infectious Disease Diagnostics Market Segmentation
Table 2. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 4. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. China: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 9. China: Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. China: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. China: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. China: Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. Japan: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 19. Japan: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. Japan: Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 21. India: Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 22. India: Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 23. India: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 24. India: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 25. India: Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 26. India: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 27. India: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 28. India: Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 30. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 31. South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 32. South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 33. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 34. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 35. South Korea: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 36. South Korea: Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 38. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 39. Australia: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 40. Australia: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 41. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 42. Australia: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 43. Australia: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 44. Australia: Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 46. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 47. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 48. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 49. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 50. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 51. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 52. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 53. Organic Developments Done By Companies
Table 54. Inorganic Developments Done By Companies
Table 55. Glossary of Terms, Asia Pacific Infectious Disease Diagnostics Market
List of Figures
Figure 1. Asia Pacific Infectious Disease Diagnostics Market Segmentation, By Country
Figure 2. Asia Pacific Infectious Disease Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 6. Kits & Reagents: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Software & Services: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
Figure 10. Biosensor-based: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunodiagnostics: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular-Based Diagnostic Techniques: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinical Biology: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
Figure 16. Point-of-Care Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Laboratory Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
Figure 19. Human Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Veterinary Testing: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Diagnostic Laboratories: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospitals and Clinics: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Research Institutes: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Homecare Settings: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific Asia Pacific Infectious Disease Diagnostics Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 28. Asia Pacific Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%)
Figure 29. China: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Japan: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. India: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. South Korea: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Australia: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Rest of Asia Pacific: Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Growth Strategies Done by the Companies in the Market, (%)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AccuBioTech Co Ltd
  • ACON Laboratories Inc
  • Bio-Rad Laboratories Inc
  • Bruker Corp
  • Cardinal Health Inc
  • Danaher Corp
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • Trinity Biotech Plc

Related Topics

Related Reports

Asia Pacific Molecular Diagnostics for Infectious Disease Market Forecast to 2030 - Regional Analysis - by Type, End User - Product Image

Asia Pacific Molecular Diagnostics for Infectious Disease Market Forecast to 2030 - Regional Analysis - by Type, End User

  • Report
  • 138 Pages
  • Asia Pacific
From
Infectious Disease Diagnostics Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Technology, Application Type, Testing Type, End User, and Geography - Product Image

Infectious Disease Diagnostics Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Technology, Application Type, Testing Type, End User, and Geography

  • Report
  • 280 Pages
  • Global
From
Molecular Diagnostic for Infectious Diseases Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, End User, Disease Type, Infection Type, and Geography - Product Image

Molecular Diagnostic for Infectious Diseases Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, End User, Disease Type, Infection Type, and Geography

  • Report
  • 331 Pages
  • Global
From
Global Infectious Disease Diagnostic Market by Product (Instruments, Reagents, Software & Services), Technology (Biochemical Technology, Conventional Technology, Molecular Technology), Testing Type, Sample, Application, End User - Forecast 2024-2030 - Product Image

Global Infectious Disease Diagnostic Market by Product (Instruments, Reagents, Software & Services), Technology (Biochemical Technology, Conventional Technology, Molecular Technology), Testing Type, Sample, Application, End User - Forecast 2024-2030

  • Report
  • 193 Pages
  • Global
From
Global Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Forecast 2024-2030 - Product Image

Global Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From

About the Infectious Disease Testing Market

The Infectious Disease Testing market is a sector of the healthcare industry that focuses on the diagnosis and treatment of infectious diseases. It includes a range of tests, such as blood tests, urine tests, and swab tests, to detect the presence of a pathogen. These tests are used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and tuberculosis. The Infectious Disease Testing market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the development of new technologies. Companies in this market are developing innovative tests and technologies to improve the accuracy and speed of diagnosis. Some of the major companies in the Infectious Disease Testing market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies are investing in research and development to develop new tests and technologies to improve the accuracy and speed of diagnosis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.